Julie Davis, PhD Appointed Head of Quality Management
Please join us in welcoming Julie to the Serac Life Sciences team as Head of Quality Management. Julie’s career has been spent in life science and radiopharmaceutical drug discovery, most recently consulting with biotech start-ups including leading the development and implementation of operational processes and quality systems.
Jon Barnett PhD, Appointed Head of CMC and Supply Chain
We are pleased to announce that Jon has joined Serac Healthcare Limited as Head of CMC and Supply Chain. With over 20 years’ experience on radiopharmaceutical and biopharmaceutical product development and commercial supply, Jon has extensive experience of leading global functional and cross-functional project / operational teams to deliver new products and life cycle improvements.
Abstract for Presentation at the European League Against Rheumatism (EULAR) Congress 2020
Results from a Phase II study evaluating the potential of 99mTc-maraciclatide to image synovial inflammation at the whole-body level will be presented at the European League Against Rheumatism (“EULAR”) Congress 2020. The oral presentation is titled, “IMAGING NEOANGIOGENESIS IN RHEUMATOID ARTHRITIS (INIRA): WHOLE-BODY SYNOVIAL UPTAKE OF A 99MTC-LABELLED RGD PEPTIDE IS HIGHLY CORRELATED WITH POWER DOPPLER ULTRASOUND” and will be delivered by Dr Laura Attipoe, Guy’s and St Thomas’ NHS Foundation Trust, London, UK.
Citation: Ann Rheum Dis, volume 79, supplement 1, year 2020, page 110
Session: Diagnostics and imaging procedures (Oral Presentations)
Colin Esbrand, PhD Appointed Head of Development (Hybrid Gamma/Optical Camera)
We are delighted to welcome Colin to Serac Imaging Systems Limited as Head of Development for the hybrid gamma/optical camera (HGC). With 14 years’ project management experience in the development of medical devices, patient recruitment and strategy development, Colin has led cross-functional global teams and worked closely with business owners.
Druin Burch FRCP, Appointed Chief Scientific Officer (CSO)
Serac Life Sciences continues to strengthen its management team with the appointment of Dr Druin Burch as Chief Scientific Officer (CSO). Druin is a Consultant Physician at the Oxford University Hospitals NHS Trust, and has three decades experience as a clinician, scientist and writer in the field of developing and testing medical technology.
Roger Humm FCA, Appointed Financial Director
We are pleased to announce that Roger joins the Serac Life Sciences team as Financial Director. Roger is a chartered accountant and experienced commercial and finance director with extensive knowledge of high growth technology companies both in the public and private markets, including diagnostics, medical devices and imaging amongst other sectors.
Abstract for Presentation at the American Congress of Rheumatology (ACR) Congress 2019
Results from an interim analysis of the first 25 patients enrolled in a study evaluating the potential of 99mTc-maraciclatide to image synovial inflammation at the whole-body level will be presented at the American College of Rheumatology (ACR) Congress. The poster is titled, “IMAGING NEOANGIOGENESIS IN RHEUMATOID ARTHRITIS (INIRA): WHOLE-BODY SYNOVIAL UPTAKE OF A 99MTC-LABELLED RGD PEPTIDE IS HIGHLY CORRELATED WITH POWER DOPPLER ULTRASOUND” and will be presented by Dr Laura Attipoe, Guy’s and St Thomas’ NHS Foundation Trust, London, UK.
Date: Sunday, November 10, 2019
Session Title: Imaging Of Rheumatic Diseases Poster I
Session Time: 9:00AM-11:00AM
Serac Imaging Systems to launch hybrid gamma optical camera
Serac Imaging Systems, based in Thames Ditton, is to launch an innovative, new hybrid Gamma Optical camera for medical applications. The new system is scheduled to be available from 2021 and will be portable, smaller, easier to use and more cost effective than anything that exists on the market today. It will bring the huge potential benefits of molecular imaging to patients whether in operating room, an intensive care unit, a physician’s office or even a remote village in the developing world.
Serac Imaging Systems to develop a compact, hybrid optical/gamma camera which will be portable, smaller, easier to use and more cost effective than anything that exists on the market today.
Serac Imaging Systems Limited (SIS), a wholly-owned subsidiary of Serac Life Sciences Limited (SLS), is developing and commercialising a novel, compact, portable, hybrid gamma/optical camera (HGC) the IP for which has been exclusively licensed from a group of universities led by the University of Leicester.
Pat Butler, Joins as Board Observer and Advisor.
Pat, a qualified Chartered Accountant, is a director of Hikma Pharmaceuticals, Chairman of Aldermore Bank and was formerly a Senior Director at McKinsey & Co. He is also a Governor of the British Film Institute and a trustee of the Resolution Foundation.
Serac Healthcare founded to develop a molecular imaging agent to help rheumatologists manage treatment decisions in their patients with rheumatoid arthritis
Serac Life Sciences Limited (SLS) announces the formation of a new company, Serac Healthcare Limited (SHC), which will develop and commercialise a novel molecular imaging agent for the detection of disease activity in rheumatoid arthritis (RA). SHC, a wholly-owned subsidiary of SLS, has acquired the molecular imaging agent maraciclatide from GE Healthcare. The goal of the company is to enable rheumatologists to “see disease activity” in the joints, informing clinicians and helping them deliver personalised care to their patients.